Wednesday, July 8, 2026

biotech · Atopic Dermatitis · Asthma · APGE

Apogee Therapeutics

Apogee Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

WALTHAM, MA, USA HQ
2022 Founded
293 Employees
Public company Type
APGE · NYSE Ticker
Company details
Status
Public
HQ
WALTHAM, MA, USA
Founded
2022
Employees
293
Programs
8
Drugs
2
Patents
7
Intelligence · Drug Pipeline

Apogee Therapeutics pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Apogee Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to Apogee Therapeutics in public FDA and regional records.

  2. Development asset linked to Apogee Therapeutics in public FDA and regional records.